These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2277692)

  • 1. The radiation dosimetry of 99Tcm-exametazime.
    Soundy RG; Tyrrell DA; Pickett RD; Stabin M
    Nucl Med Commun; 1990 Nov; 11(11):791-9. PubMed ID: 2277692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
    Marshall DS; Newberry NR; Ryan PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO.
    Villanueva-Meyer J; Thompson D; Mena I; Marcus CS
    J Nucl Med; 1990 Jul; 31(7):1237-9. PubMed ID: 2362204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dosimetry of 99Tcm-exametazime (Ceretec).
    Pickett RD; Wright A; Sheppard HC
    Nucl Med Commun; 1995 May; 16(5):417. PubMed ID: 7659392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of radiation exposure from the use of 99mTc-HM-PAO].
    Ertl S; Tautz M; Deckart H; Blottner A
    Radiobiol Radiother (Berl); 1990; 31(2):197-201. PubMed ID: 2356304
    [No Abstract]   [Full Text] [Related]  

  • 7. Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content?
    el-Shirbiny AM; Sadek S; Owunwanne A; Yacoub T; Suresh L; Abdel-Dayem HM
    Nucl Med Commun; 1989 Dec; 10(12):905-11. PubMed ID: 2622593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorbed radiation dose to humans from technetium-99m-teboroxime.
    Narra RK; Feld T; Nunn AD
    J Nucl Med; 1992 Jan; 33(1):88-93. PubMed ID: 1731003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
    Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH
    Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
    Van de Wiele C; Dumont F; Dierckx RA; Peers SH; Thornback JR; Slegers G; Thierens H
    J Nucl Med; 2001 Nov; 42(11):1722-7. PubMed ID: 11696645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99Tcm-phenylene imine phenol as a potential leukocyte labelling agent.
    Huang WT; Lo JM; Kao CH; Wang SJ
    Nucl Med Commun; 1997 Jan; 18(1):66-9. PubMed ID: 9061704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopharmaceutical dosage of 99Tcm-HMPAO for cerebral blood flow SPET studies in children.
    Vestergren E; Jacobsson L; Bjure J; Sixt R; Mattsson S
    Nucl Med Commun; 1996 May; 17(5):423-9. PubMed ID: 8736520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99Tcm-HMPAO SPET and cerebral blood flow: a study of CO2 reactivity.
    Choksey MS; Costa DC; Iannotti F; Ell PJ; Crockard HA
    Nucl Med Commun; 1989 Aug; 10(8):609-18. PubMed ID: 2510102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral voluntary hand movement and regional cerebral uptake of technetium-99m-exametazime in human control subjects.
    Ebmeier KP; Murray CL; Dougall NJ; O'Carroll RE; Goodwin GM
    J Nucl Med; 1992 Sep; 33(9):1623-7. PubMed ID: 1517835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
    Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
    Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biodistribution of technetium-99m-hexamethylpropylene amine oxime.
    Shih WJ; Coupal J; Magoun S
    Semin Nucl Med; 1994 Apr; 24(2):180-3. PubMed ID: 8023173
    [No Abstract]   [Full Text] [Related]  

  • 18. Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.
    Van Den Bossche B; D'haeninck E; Bacher K; Thierens H; Van Belle S; Dierckx RA; Van de Wiele C
    Cancer Biother Radiopharm; 2004 Dec; 19(6):776-83. PubMed ID: 15665627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the effective dose equivalent, HE, for 99mTc labelled radiopharmaceuticals.
    Huda W; Sandison GA
    Eur J Nucl Med; 1989; 15(4):174-9. PubMed ID: 2753049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-HMPAO retention and the role of glutathione: the debate continues.
    Babich JW
    J Nucl Med; 1991 Sep; 32(9):1681-3. PubMed ID: 1880568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.